Search

everythinglearnresearchcommunity

for

Search:↓

No single treatment is consistently effective for alopecia areata, and more research is needed.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

Ginseng and its compounds may help hair growth and prevent hair loss, but more human trials are needed to confirm this.

Cells from a skin condition can create new hair follicles and similar growths in mice, and a specific treatment can reduce these effects.

Using systemic drugs as creams for skin conditions shows promise, but more research is needed to confirm their effectiveness and safety.

Lupus treatment requires a combination of drugs and therapies, with research needed for new options.

Genetic factors affect hair loss, and molecular testing may help predict, diagnose, and treat it.

Frontal fibrosing alopecia in families shows similar signs to individual cases and may have a genetic link.

Hair loss from alopecia areata and androgenetic alopecia can be treated, but more effective and safer treatments are needed.

The document concludes that various childhood hair and nail disorders exist, some may improve on their own, and advances in genetics and immunology could enhance treatment and counseling.

The Alopecia Areata Assessment Tool (ALTO) effectively identifies alopecia areata from other hair loss types but needs more validation.

The document concludes that autoimmune skin disorders are treated with corticosteroids and immunosuppressive drugs.

Garudan Kizhangu Ennai may effectively treat alopecia areata but needs more research to confirm its safety and effectiveness.

Alopecia areata involves persistent gene abnormalities and immune activity, even in regrown hair, suggesting a risk of relapse.

miR-199a-3p controls hair growth and is linked to alopecia areata.

Natural products and phytochemicals may help with hair regrowth, but more research is needed.

Tofacitinib may effectively treat hair loss and improve symptoms in autoimmune conditions like alopecia areata and Sjögren's syndrome, but long-term treatment might be necessary.

Wharton’s Jelly stem cells from the umbilical cord improve skin healing and hair growth without scarring.

Janus kinase inhibitors show promise in treating alopecia areata but need better topical formulations.

Nonantibiotic macrolides show promise for treating various inflammatory skin conditions.

Type 1 diabetes often occurs with other autoimmune diseases, and personalized treatment based on genetics can improve outcomes.

New regenerative treatments for hair loss show promise but need more research for confirmation.

People with Type 2 Diabetes are more likely to have a mite infestation called Demodex folliculorum.

Low oxygen conditions improve how well certain stem cells from embryos can make hair grow longer and faster.

Leptin, a hormone from fat cells, affects immune responses and can influence skin diseases and hair growth.

Protein tyrosine kinases are key in male pattern baldness, affecting skin structure, hair growth, and immune responses.

Some drugs can cause skin, nail, and hair problems, which are important for healthcare professionals to recognize and report.

Skin reactions to drugs are common and can be deadly, usually requiring stopping the drug and may be better prevented with genetic testing in the future.

2011 dermatology discussions highlighted stem cell hair treatments, new lichen planopilaris therapies, skin side effects from cancer drugs, emerging allergens, and the link between food allergies and skin issues.

Topoisomerase inhibitors can cause hair loss, skin rash, hand-foot syndrome, and nail changes.